Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology Group

被引:1
|
作者
Bolukbasi, Yasemin [1 ,2 ]
Onal, Cem [3 ]
Ozsaran, Zeynep [4 ]
Senyurek, Sukran [1 ]
Akdemir, Eyub Yasar [1 ]
Selek, Ugur [1 ]
Yildiz, Ferah [5 ]
机构
[1] Koc Univ, Fac Med, Dept Radiat Oncol, Davutpasa Caddesi 4, TR-34010 Istanbul, Turkey
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana Dr Turgut Noyan Res & Treatment Ctr, Adana, Turkey
[4] Ege Univ, Fac Med, Dept Radiat Oncol, Izmir, Turkey
[5] Hacettepe Univ Ankara, Fac Med, Dept Radiat Oncol, Ankara, Turkey
关键词
brachytherapy; vaginal cuff; experience; survey; DOSE-RATE BRACHYTHERAPY; AMERICAN BRACHYTHERAPY; PRACTICE PATTERNS; RISK; RADIOTHERAPY; ORGANS; DOSIMETRY; CARCINOMA; STENOSIS; TRENDS;
D O I
10.5114/jcb.2021.105282
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The American Brachytherapy Association is attempting to develop standards for delivering brachytherapy, although differences in practice have been reported in the literature. This study evaluated vaginal cuff brachytherapy (VBT) practice and quality of life-related recommendations among Turkish radiation oncologists. Material and methods: A nationwide web-based 17-item survey was distributed to the members of the Turkish Society for Radiation Oncology. These members received e-mail notifications, and a link was posted on the Turkish Society for Radiation Oncology internet site to solicit voluntary responses The survey addressed the simulation processes, target volume, prescribed dose, delivery schedules, and recommendations related to vaginal side effects. Results: Fifty-seven radiation oncologists responded to the survey. The most used dose fraction schemes for adjuvant VBT were 7 Gy x 3 fractions (30%), 5.5 Gy x 5 fractions (26%), and 6 Gy x 5 fractions (28%). The preferred VBT scheme was 5 Gy x 3 fractions (50%) when the external beam radiotherapy (EBRT) dose was 45 Gy external radiotherapy, while the preferred schemes were 6 Gy x 3 fractions (30%) or 5 Gy x 3 fractions (32%) when the external radiotherapy dose was increased to 50.4 Gy. One-half of the respondents delivered VBT twice a week, and the dose was prescribed to 0.5 cm from vaginal mucosa by 86% of the respondents. There was no common definition for the dose prescription length, which was defined as 3 cm from the vaginal cuff in 33% of responses and as 4 cm in 35% of responses. For serous and clear cell histological types, 38% of the respondents targeted "full cylinder length". To prevent vaginal side effects, 78% of the respondents recommended using a vaginal dilator and/or sexual intercourse after VBT. Conclusions: This survey revealed variations in the clinical practice of VBT among Turkish radiation oncologists, which suggests that standardization is necessary.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [41] External radiotherapy versus vaginal brachytherapy for patients with inteimediate risk endometrial cancer
    Lin, Lilie L.
    Mutch, David G.
    Rader, Janet S.
    Powell, Matthew A.
    Grigsby, Perry W.
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 215 - 220
  • [42] Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer
    Gultekin, Melis
    Yilmaz, Melek Tugce
    Biltekin, Fatih
    Yuce, Deniz
    Sari, Sezin Yuce
    Akyol, Fadil
    Yildiz, Ferah
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 601 - 605
  • [43] HIGH-DOSE-RATE VAGINAL CUFF BRACHYTHERAPY IN STAGE I ENDOMETRIAL CANCER: THE UNIVERSITY OF WISCONSIN EXPERIENCE
    Anderson, B.
    Bentzen, S.
    Platta, C.
    Bradley, K.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S49 - +
  • [44] Is vaginal brachytherapy necessary in patients with early stage, high risk endometrial cancer?
    Boitano, Teresa
    Kincaid, Kaitlyn
    Straughn, J. Michael
    Smith, Haller
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S110 - S111
  • [45] Acute Side Effects and Outcome in Endometrial Cancer Patients after vaginal Brachytherapy
    Scharl, S.
    Duma, M. -N
    Weidenbaecher, B.
    Lemmer, S.
    Hugo, C.
    Combs, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S134 - S135
  • [46] Does chemotherapy increase the pelvic toxicity of vaginal brachytherapy for endometrial cancer patients?
    Nieto, K.
    Martin, B.
    Palmere, L.
    Brennan, K.
    Pham, N.
    Albuquerque, K.
    Liotta, M.
    Small, W.
    Harkenrider, M.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 187 - 188
  • [47] THE COMPARISON OF VAGINAL CUFF BRACHYTHERAPY AND EXTERNAL PELVIC RADIATION THERAPY IN STAGE IB GRADE 3 ENDOMETRIAL CANCER
    Esen, Caglayan Selenge Beduk
    Kahvecioglu, Alper
    Yigit, Ecem
    Yedekci, Fazli Yagiz
    Sari, Sezin Yuce
    Gultekin, Melis
    Yildiz, Ferah
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A197 - A197
  • [48] Vaginal brachytherapy: New treatment of choice for endometrial cancer?
    Nout, Remi
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1614 - 1614
  • [49] Influence of robotic-assisted laparoscopic hysterectomy on vaginal cuff healing and brachytherapy initiation in endometrial carcinoma patients
    Stahl, John M.
    Park, Henry S.
    Silasi, Dan-Arin
    Azodi, Masoud
    Damast, Shari
    PRACTICAL RADIATION ONCOLOGY, 2016, 6 (04) : 226 - 232
  • [50] Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial
    DeCesaris, Cristina
    Wilson, Trevor
    Kim, Jaewhan
    Burt, Lindsay
    Grant, Jonathan
    Harkenrider, Matthew M.
    Huang, Jessica
    Jhingran, Anuja
    Kidd, Elizabeth
    Konski, Andre
    Lin, Lilie
    Small Jr, William
    Suneja, Gita
    Gaffney, David
    PRACTICAL RADIATION ONCOLOGY, 2024, 14 (06)